281 related articles for article (PubMed ID: 27681004)
21. Development of a Method of Measuring β-D-Glucan and Its Use in Preemptive Therapy for Invasive Fungal Infections.
Yoshida M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502174
[TBL] [Abstract][Full Text] [Related]
22. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers.
Cornu M; Sendid B; Mery A; François N; Mikulska M; Letscher-Bru V; De Carolis E; Damonti L; Titecat M; Bochud PY; Alanio A; Sanguinetti M; Viscoli C; Herbrecht R; Guerardel Y; Poulain D
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787140
[TBL] [Abstract][Full Text] [Related]
24. Antifungal stewardship considerations for adults and pediatrics.
Hamdy RF; Zaoutis TE; Seo SK
Virulence; 2017 Aug; 8(6):658-672. PubMed ID: 27588344
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of invasive fungal disease in children: a narrative review.
Saffioti C; Mesini A; Bandettini R; Castagnola E
Expert Rev Anti Infect Ther; 2019 Nov; 17(11):895-909. PubMed ID: 31694414
[No Abstract] [Full Text] [Related]
26. Invasive mycoses: diagnostic challenges.
Ostrosky-Zeichner L
Am J Med; 2012 Jan; 125(1 Suppl):S14-24. PubMed ID: 22196205
[TBL] [Abstract][Full Text] [Related]
27. The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).
Lortholary O; Fernández-Ruiz M; Perfect JR
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii31-ii36. PubMed ID: 27880667
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections.
Job KM; Olson J; Stockmann C; Constance JE; Enioutina EY; Rower JE; Linakis MW; Balch AH; Yu T; Liu X; Thorell EA; Sherwin CM
Expert Rev Anti Infect Ther; 2016 Aug; 14(8):731-46. PubMed ID: 27355512
[TBL] [Abstract][Full Text] [Related]
29. Invasive fungal infection in patients with hematologic disorders in a Brazilian tertiary care hospital.
Camplesi M; Silva HM; Arantes AM; Costa CR; Ataides FS; Silva TC; Reis MP; Silva MD
Rev Soc Bras Med Trop; 2017; 50(1):80-85. PubMed ID: 28327806
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
31. Complications of invasive mycoses in organ transplant recipients.
Samanta P; Singh N
Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1195-1202. PubMed ID: 27690694
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
[TBL] [Abstract][Full Text] [Related]
33. Use of (1→3)-β-d-glucan for diagnosis and management of invasive mycoses in HIV-infected patients.
Farhour Z; Mehraj V; Chen J; Ramendra R; Lu H; Routy JP
Mycoses; 2018 Oct; 61(10):718-722. PubMed ID: 29855088
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients.
John J; Loo A; Mazur S; Walsh TJ
Expert Opin Drug Metab Toxicol; 2019 Nov; 15(11):881-895. PubMed ID: 31550939
[No Abstract] [Full Text] [Related]
35. Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.
Huppler AR; Fisher BT; Lehrnbecher T; Walsh TJ; Steinbach WJ
J Pediatric Infect Dis Soc; 2017 Sep; 6(suppl_1):S32-S44. PubMed ID: 28927202
[TBL] [Abstract][Full Text] [Related]
36. [Serologic diagnosis of fungal infections].
Fujita S
Nihon Rinsho; 2008 Dec; 66(12):2313-8. PubMed ID: 19069098
[TBL] [Abstract][Full Text] [Related]
37. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.
Levesque E; Rizk F; Noorah Z; Aït-Ammar N; Cordonnier-Jourdin C; El Anbassi S; Bonnal C; Azoulay D; Merle JC; Botterel F
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422065
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and treatment of invasive fungal infections: looking ahead.
Sanguinetti M; Posteraro B; Beigelman-Aubry C; Lamoth F; Dunet V; Slavin M; Richardson MD
J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii27-ii37. PubMed ID: 31222314
[TBL] [Abstract][Full Text] [Related]
39. [Early diagnosis of invasive fungal infections caused by Aspergillus and other emerging mycelial fungi].
del Palacio A; Alhambra A; Cuétara MS; Pontón J
Rev Iberoam Micol; 2007 Sep; 24(3):187-97. PubMed ID: 17874855
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in the treatment of life-threatening, invasive fungal infections.
Drew RH; Townsend ML; Pound MW; Johnson SW; Perfect JR
Expert Opin Pharmacother; 2013 Dec; 14(17):2361-74. PubMed ID: 24050675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
